Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smedema, J.-P.
Right arrow Articles by Crijns, H. J. G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smedema, J.-P.
Right arrow Articles by Crijns, H. J. G. M.
(Chest. 2005;128:1629-1637.)
© 2005 American College of Chest Physicians

The Additional Value of Gadolinium-Enhanced MRI to Standard Assessment for Cardiac Involvement in Patients With Pulmonary Sarcoidosis*

Jan-Peter Smedema, MD, MMed(Int); Gabriel Snoep, MD; Marinus P. G. van Kroonenburgh, MD, PhD; Robert-Jan van Geuns, MD, PhD; Emiel C. Cheriex, MD, PhD; Anton P. M. Gorgels, MD, PhD and Harry J. G. M. Crijns, MD, PhD

* From the Departments of Cardiology (Drs. Smedema, Cheriex, Gorgels, and Crijns), Radiology (Dr. Snoep), and Nuclear Medicine (Dr. van Kroonenburgh), University Hospital Maastricht, Maastricht; and Department of Cardiology and Radiology (Dr. van Geuns), Erasmus Medical Centre, Rotterdam, the Netherlands.

Correspondence to: Jan-Peter Smedema, MD, MMed(Int), Department of Cardiology, University Hospital Maastricht, Dr Debyelaan 25, 6202 AZ Maastricht, the Netherlands; e-mail: jansmedema{at}hotmail.com

Aim: To determine whether gadolinium-enhanced cardiac MRI (CMR) was of additional diagnostic value to standard assessment in patients with sarcoidosis who underwent evaluation for cardiac involvement.

Methods: We reviewed the findings in patients with pulmonary sarcoidosis who had been assessed with ECG, Doppler echocardiography, 201Tl scintigraphy, and CMR from 2002 to 2004.

Results: Of the 55 evaluated patients, standard evaluation diagnosed cardiac involvement in 13 patients while CMR diagnosed myocardial scarring (mean ± SD, 2.5 ± 1.9 segments) [all 6 patients] and impaired systolic left ventricular function (1 patient) in an additional 6 patients. The extent of delayed enhancement correlated with disease duration (p < 0.05), ventricular dimensions and function (p < 0.001), severity of mitral regurgitation (p < 0.05), and the presence of ventricular tachycardias (p < 0.001). Patients in whom cardiac involvement was diagnosed only with CMR had less myocardial scarring and functional impairment (p < 0.05) compared to patients with a diagnosis made by standard assessment.

Conclusion: CMR provides an accurate estimation of the extent of cardiac involvement and may reveal signs of early infiltration that are not detected by standard assessment. The extent of late enhancement with gadolinium relates to the severity of cardiac involvement and may therefore have prognostic implications.

Key Words: Doppler echocardiography • MRI • myocardial fibrosis • myocardial scintigraphy




This article has been cited by other articles:


Home page
 NEJMHome page
S. C. Plastiras, N. Kelekis, and G. E. Tzelepis
Magnetic Resonance Imaging for the Detection of Myocardial Fibrosis in Scleroderma
N. Engl. J. Med., May 18, 2006; 354(20): 2194 - 2196.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.